NRXS AMEX
NeurAxis, Inc.
1W: -6.0%
1M: +19.5%
3M: -0.7%
YTD: +59.4%
1Y: +128.6%
3Y: +74.7%
$7.11
-0.06 (-0.84%)
Weekly Expected Move ±13.7%
$5
$6
$7
$8
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$88.7M
52W Range2.21-9.33
Volume47,405
Avg Volume110,209
Beta1.45
Dividend—
Analyst Ratings
Company Info
CEOBrian Carrico
Employees24
SectorHealthcare
IndustryBiotechnology
IPO Date2023-08-09
Websiteneuraxis.com
11550 North Meridian Street
Carmel, IN 46032
US
Carmel, IN 46032
US
(812) 689-0791
About NeurAxis, Inc.
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Blanchard Craig Thom | 0 | — | 2026-09-28 | |
| Carrico Thomas Joese | A-Award | 193,678 | — | 2026-08-24 |
| Carrico Thomas Joese | C-Conversion | 306,236 | — | 2026-08-24 |
| Carrico Thomas Joese | A-Award | 306,236 | — | 2026-08-24 |
| Carrico Thomas Joese | C-Conversion | 306,236 | — | 2026-08-24 |